...
Can platelet-rich plasma (PRP) support sensitivity or orgasms in selected patients
Can platelet-rich plasma (PRP) support sensitivity or orgasms in selected patients

Can platelet-rich plasma (PRP) support sensitivity or orgasms in selected patients?

Platelet-rich plasma (PRP) is an autologous treatment that uses concentrated growth factors from your own blood to stimulate tissue regeneration and nerve health in the genital area. Early clinical evidence suggests PRP may improve clitoral sensitivity, vaginal tissue responsiveness, and orgasmic function in women experiencing reduced sexual sensation due to ageing, hormonal changes, or nerve damage. However, it is not a guaranteed solution and outcomes vary significantly between individuals.

Show Detailed Answer

Sexual sensitivity and orgasmic capacity are influenced by multiple factors: nerve density and function, blood flow to erectile tissue (clitoris and vestibular bulbs), hormonal status (particularly oestrogen and testosterone), psychological arousal, and pelvic floor muscle coordination. When these systems are compromised—whether through menopause, childbirth trauma, diabetes, certain medications, or simple ageing—many women notice a gradual decline in sensation, arousal, or the ability to reach climax.

This change can be deeply distressing. It often occurs silently, with women feeling embarrassed to raise it with clinicians or partners. The emotional impact includes loss of confidence, relationship strain, and a sense of disconnection from one’s own body. PRP has emerged as a regenerative option that aims to address the biological underpinnings of reduced sensation by promoting tissue repair, vascularisation, and nerve regeneration at a cellular level.

How PRP Works for Sexual Function

PRP is derived by drawing a small amount of your own blood, spinning it in a centrifuge to concentrate the platelets, and then injecting the platelet-rich portion into targeted areas of the vulva and vagina. Platelets contain growth factors—including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and transforming growth factor-beta (TGF-β)—which:

  • Stimulate new blood vessel formation (angiogenesis): Improved blood flow to the clitoris and vaginal walls enhances engorgement and natural lubrication during arousal.
  • Support nerve regeneration: Growth factors may promote the repair and growth of sensory nerve endings, which are critical for detecting touch, vibration, and pleasure.
  • Enhance collagen and elastin production: This improves tissue thickness, elasticity, and resilience, reversing some of the thinning (atrophy) caused by low oestrogen.
  • Modulate inflammation: Chronic low-grade inflammation can damage tissue; PRP may help regulate this response.

Who Might Benefit?

PRP for sexual sensitivity is considered investigational, but clinical experience and emerging research suggest potential benefit in specific groups:

  • Postmenopausal women with Genitourinary Syndrome of Menopause (GSM): Particularly those who have incomplete response to topical oestrogen or prefer a non-hormonal option.
  • Women with post-childbirth changes: Including scarring, nerve stretch injury, or persistent reduction in sensation despite pelvic floor physiotherapy.
  • Those with lichen sclerosus: As an adjunct to standard treatment (topical steroids) to improve tissue quality and nerve function.
  • Individuals with orgasmic dysfunction or anorgasmia: Especially when linked to reduced clitoral sensitivity rather than psychological or relational factors alone.
  • Women on certain medications: Such as SSRIs (antidepressants), which can blunt sexual response, though PRP does not reverse the central nervous system effects of these drugs.

What the Evidence Shows

Clinical trials on PRP for female sexual dysfunction are still limited but growing. A 2021 systematic review in the Journal of Sexual Medicine found that PRP injections were associated with statistically significant improvements in Female Sexual Function Index (FSFI) scores, particularly in the domains of arousal, lubrication, and orgasm. However, study quality varied, sample sizes were small, and placebo effects have not been fully controlled.

PRP is not approved by the MHRA or FDA specifically for sexual enhancement, and it is offered as an “off-label” regenerative treatment. It should not be considered a first-line therapy; optimising hormones, addressing pelvic floor dysfunction, and ensuring psychological wellbeing remain foundational.

Common Concerns & Myths

“Will PRP give me immediate results?”
No. PRP works by stimulating your body’s own healing processes, which take time. Most patients notice gradual changes over 6–12 weeks, with optimal results after 2–3 treatments spaced 4–6 weeks apart.

“Is it painful?”
The injection sites (typically clitoris and anterior vaginal wall) are numbed with topical anaesthetic or local injection beforehand. Most describe mild pressure or brief stinging rather than severe pain.

“Can PRP replace hormone therapy?”
No. PRP addresses tissue structure and nerve health, but it does not replace systemic or local oestrogen when hormone deficiency is the root cause. Many clinicians use both together.

“Is it safe?”
Because PRP uses your own blood, the risk of allergic reaction or rejection is extremely low. Risks include bruising, mild swelling, temporary discomfort, and rare infection at the injection site.

Clinical Context

Sexual health is an integral part of overall wellbeing, yet reduced sensitivity and orgasmic difficulty are often under-reported and under-treated. These symptoms are not “just part of ageing” or something you must accept. PRP represents one option within a broader regenerative medicine toolkit that also includes laser therapy, radiofrequency, and targeted physiotherapy. It is most effective when integrated into a holistic care plan that includes hormone optimisation, pelvic floor rehabilitation, and psychosexual support where needed. Educational only. Results vary. Not a cure.

Evidence-Based Approaches

Self-Care & Lifestyle

Before or alongside PRP, optimising foundational health can improve baseline tissue and nerve function.

  • Pelvic floor awareness: Engage with specialist pelvic health physiotherapy to release tension and improve voluntary control, which supports arousal and orgasm.
  • Mindfulness and sensate focus: Techniques that help reconnect with bodily sensations and reduce performance anxiety.
  • Adequate sleep and stress management: Chronic stress and poor sleep suppress libido and arousal via cortisol and autonomic dysregulation.
  • Avoid smoking: Nicotine damages small blood vessels, reducing clitoral and vaginal blood flow.

Medical & Specialist Options

PRP is part of a stepwise approach. Standard medical options should be optimised first:

  • Topical or systemic oestrogen: Restores vaginal and vulvar tissue health and improves nerve function in postmenopausal women.
  • Testosterone therapy: Used off-label in the UK for women with low desire and arousal; may improve clitoral sensitivity when deficiency is confirmed.
  • Laser or radiofrequency treatments: Stimulate collagen production and tissue rejuvenation; can be combined with PRP.
  • Psychosexual therapy: Especially helpful when there is a learned fear-avoidance cycle or relationship issues.

If you are considering PRP, it is important to meet the clinical team who will assess your suitability and ensure the technique is performed safely. You may also wish to book a consultation to discuss your symptoms and treatment goals in detail.

C. Red Flags (When to see a GP urgently)

Sudden complete loss of genital sensation, new neurological symptoms (numbness, tingling in legs or buttocks), or unexplained pelvic pain warrant urgent medical review to rule out nerve compression or serious underlying conditions.

External Resources:

Educational only. Results vary. Not a cure.

Safety Guide: The "No Sex" rule varies by technology. For Laser, it prevents infection of open micro-wounds. For Fillers, it prevents the gel from moving (migration). For PRP, it prevents bruising. See the specific timelines below.

Sexual Abstinence Timelines

CO2 Laser (Ablative)

Wait Time: 5–7 Days

  • Why? Fractional lasers drill microscopic holes (channels) into the vaginal wall. These are open wounds.
  • The Risk: Sex before day 5 forces bacteria into these deep channels, causing infection or scarring. You must wait until all discharge stops.
Fillers (Hyaluronic Acid / G-Shot)

Wait Time: 3–5 Days.

  • The Risk: Migration. The filler gel is malleable (like wet clay) for the first few days. The friction and pressure of intercourse can physically push the filler out of the intended spot, causing lumps or asymmetry.
The O-Shot (PRP)

Wait Time: 24 Hours (minimum).

  • The Reason: While the injection is deep, the entry points need to seal to prevent bacteria entering.
  • The Bigger Risk (Medication): It is not just about sex. You must avoid NSAIDs (Ibuprofen/Aspirin) for 7 days before and after. These drugs chemically deactivate platelets, stopping them from releasing the growth factors that make the treatment work.
Polynucleotides (PhilArt / Plinest)

Wait Time: 48–72 Hours.

  • The Reason: These injections often leave small fluid bumps ("blebs") under the skin surface. Friction can irritate these bumps or cause the product to diffuse too quickly away from the target area.
Disclaimer: These are general medical guidelines. If you experience bleeding, fever, or offensive discharge, do not resume sexual activity and contact the clinic immediately.